Since recent therapies are targeting LRRK2 kinase activity, we found relevant to study LRRK2-PD different regional vulnerability of brainstem dopaminergic neurons to achieve specific neuroimaging signatures that can help to easily monitor disease staging. Here, LRRK2 is linked to Parkinson disease.